BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22892600)

  • 1. Expression of the receptor for type i insulin-like growth factor (IGF1R) in gastrointestinal stromal tumors: an immunohistochemical study of 1078 cases with diagnostic and therapeutic implications.
    Lasota J; Wang Z; Kim SY; Helman L; Miettinen M
    Am J Surg Pathol; 2013 Jan; 37(1):114-9. PubMed ID: 22892600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression of the IGF pathway family distinguishes subsets of gastrointestinal stromal tumors wild type for KIT and PDGFRA.
    Beadling C; Patterson J; Justusson E; Nelson D; Pantaleo MA; Hornick JL; Chacón M; Corless CL; Heinrich MC
    Cancer Med; 2013 Feb; 2(1):21-31. PubMed ID: 24133624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors.
    Belinsky MG; Rink L; Flieder DB; Jahromi MS; Schiffman JD; Godwin AK; von Mehren M
    Genes Chromosomes Cancer; 2013 Feb; 52(2):214-24. PubMed ID: 23109135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Succinate dehydrogenase-deficient GISTs are characterized by IGF1R overexpression.
    Chou A; Chen J; Clarkson A; Samra JS; Clifton-Bligh RJ; Hugh TJ; Gill AJ
    Mod Pathol; 2012 Sep; 25(9):1307-13. PubMed ID: 22555179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunohistochemical study of potential diagnostic and therapeutic biomarkers of wild-type gastrointestinal stromal tumours.
    Wong NA; Wingate J; Gradhand E
    Histopathology; 2015 Sep; 67(3):378-85. PubMed ID: 25659413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical loss of succinate dehydrogenase subunit A (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation.
    Miettinen M; Killian JK; Wang ZF; Lasota J; Lau C; Jones L; Walker R; Pineda M; Zhu YJ; Kim SY; Helman L; Meltzer P
    Am J Surg Pathol; 2013 Feb; 37(2):234-40. PubMed ID: 23282968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor 1 receptor expression in wild-type GISTs: a potential novel therapeutic target.
    Pantaleo MA; Astolfi A; Di Battista M; Heinrich MC; Paterini P; Scotlandi K; Santini D; Catena F; Manara MC; Nannini M; Maleddu A; Saponara M; Lolli C; Formica S; Biasco G
    Int J Cancer; 2009 Dec; 125(12):2991-4. PubMed ID: 19672856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age.
    Miettinen M; Wang ZF; Sarlomo-Rikala M; Osuch C; Rutkowski P; Lasota J
    Am J Surg Pathol; 2011 Nov; 35(11):1712-21. PubMed ID: 21997692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
    Miettinen M; Wang ZF; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction.
    Nannini M; Astolfi A; Paterini P; Urbini M; Santini D; Catena F; Indio V; Casadio R; Pinna AD; Biasco G; Pantaleo MA
    Future Oncol; 2013 Jan; 9(1):121-6. PubMed ID: 23252569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of immunohistochemical investigation of SDHB and molecular genetic analysis of SDH genes in the differential diagnosis of mesenchymal tumors of GIT.
    Dubova M; Sedivcova M; Michal M; Kokoskova B; Ryska A; Smid D; Daum O
    Histol Histopathol; 2015 Feb; 30(2):223-32. PubMed ID: 25205505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strong expression of IGF1R in pediatric gastrointestinal stromal tumors without IGF1R genomic amplification.
    Janeway KA; Zhu MJ; Barretina J; Perez-Atayde A; Demetri GD; Fletcher JA
    Int J Cancer; 2010 Dec; 127(11):2718-22. PubMed ID: 20162573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Succinate dehydrogenase-deficient gastrointestinal stromal tumors.
    Wang YM; Gu ML; Ji F
    World J Gastroenterol; 2015 Feb; 21(8):2303-14. PubMed ID: 25741136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors.
    Tarn C; Rink L; Merkel E; Flieder D; Pathak H; Koumbi D; Testa JR; Eisenberg B; von Mehren M; Godwin AK
    Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8387-92. PubMed ID: 18550829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations.
    Janeway KA; Kim SY; Lodish M; Nosé V; Rustin P; Gaal J; Dahia PL; Liegl B; Ball ER; Raygada M; Lai AH; Kelly L; Hornick JL; ; O'Sullivan M; de Krijger RR; Dinjens WN; Demetri GD; Antonescu CR; Fletcher JA; Helman L; Stratakis CA
    Proc Natl Acad Sci U S A; 2011 Jan; 108(1):314-8. PubMed ID: 21173220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents.
    Ricci R; Martini M; Ravegnini G; Cenci T; Milione M; Lanza P; Pierconti F; Santini D; Angelini S; Biondi A; Rosa F; Alfieri S; Clemente G; Persiani R; Cassano A; Pantaleo MA; Larocca LM
    Clin Epigenetics; 2019 Jan; 11(1):2. PubMed ID: 30616628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors.
    Celestino R; Lima J; Faustino A; Vinagre J; Máximo V; Gouveia A; Soares P; Lopes JM
    Eur J Hum Genet; 2013 May; 21(5):503-10. PubMed ID: 22948025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Succinate dehydrogenase deficiency is associated with decreased 5-hydroxymethylcytosine production in gastrointestinal stromal tumors: implications for mechanisms of tumorigenesis.
    Mason EF; Hornick JL
    Mod Pathol; 2013 Nov; 26(11):1492-7. PubMed ID: 23743927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SDHB immunohistochemistry: a useful tool in the diagnosis of Carney-Stratakis and Carney triad gastrointestinal stromal tumors.
    Gaal J; Stratakis CA; Carney JA; Ball ER; Korpershoek E; Lodish MB; Levy I; Xekouki P; van Nederveen FH; den Bakker MA; O'Sullivan M; Dinjens WN; de Krijger RR
    Mod Pathol; 2011 Jan; 24(1):147-51. PubMed ID: 20890271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SDHA loss of function mutations in a subset of young adult wild-type gastrointestinal stromal tumors.
    Italiano A; Chen CL; Sung YS; Singer S; DeMatteo RP; LaQuaglia MP; Besmer P; Socci N; Antonescu CR
    BMC Cancer; 2012 Sep; 12():408. PubMed ID: 22974104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.